Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Charlotte Brouwer, Joachim Hebe, Jan-Hendrik Nürnberg, Jens Cosedis Nielsen, Peter Lukac, Marta de Riva, Nico Blom, Katja Zeppenfeld
BACKGROUND: Atrial tachycardia (AT) and atrial fibrillation (AF) coexist in 30% of congenital heart disease (CHD) patients. Successful atrial tachycardia catheter ablation (ATCA) might prevent AF. Data on new-onset AF after ATCA in CHD is scarce. OBJECTIVES: This study aimed to evaluate the incidence of new-onset AF after ATCA and to assess clinical characteristics associated with new-onset AF after ATCA in CHD. METHODS: CHD patients referred for ATCA to 3 European centers were included...
March 28, 2024: JACC. Clinical Electrophysiology
#2
JOURNAL ARTICLE
Karim Benali, Cinzia Monaco, Josselin Duchateau, Frederic Sacher, Michel Haïssaguerre
No abstract text is available yet for this article.
March 26, 2024: JACC. Clinical Electrophysiology
#3
JOURNAL ARTICLE
Jeremy N Ruskin, A John Camm, Christopher Dufton, Anderson C Woite-Silva, Ype Tuininga, Erik Badings, Jonas S S G De Jong, Thomas Oosterhof, Ismail Aksoy, Aaf F M Kuijper, Isabelle C Van Gelder, Vincent van Dijk, Dieter Nuyens, Dirk Schellings, Mark Young Lee, Peter R Kowey, Harry J G M Crijns, Jean Maupas, Luiz Belardinelli
BACKGROUND: INSTANT (INhalation of flecainide to convert recent-onset SympTomatic Atrial fibrillatioN to sinus rhyThm) was a multicenter, open-label, single-arm study of flecainide acetate oral inhalation solution (FlecIH) for acute conversion of recent-onset (≤48 hours) symptomatic atrial fibrillation (AF) to sinus rhythm. OBJECTIVES: This study investigated the efficacy and safety in 98 patients receiving a single dose of FlecIH delivered via oral inhalation...
March 26, 2024: JACC. Clinical Electrophysiology
#4
EDITORIAL
Ratika Parkash, Edward P Gerstenfeld
No abstract text is available yet for this article.
March 22, 2024: JACC. Clinical Electrophysiology
#5
JOURNAL ARTICLE
Benjamin De Becker, Clara Francois, Maarten De Smet, René Tavernier, Mattias Duytschaever, Sébastien Knecht, Jean-Benoit le Polain de Waroux
No abstract text is available yet for this article.
March 22, 2024: JACC. Clinical Electrophysiology
#6
LETTER
Balaram Krishna Hanumanthu, David Callans, Francis E Marchlinski, Saman Nazarian, Timothy M Markman
No abstract text is available yet for this article.
March 21, 2024: JACC. Clinical Electrophysiology
#7
JOURNAL ARTICLE
Kazutaka Nakasone, Shumpei Mori, Yu Izawa, Kimitake Imamura, Mitsuru Takami, Ken-Ichi Hirata, Koji Fukuzawa
No abstract text is available yet for this article.
March 21, 2024: JACC. Clinical Electrophysiology
#8
LETTER
Satoshi Yanagisawa, Yasuya Inden, Tomoya Iwawaki, Masaya Tachi, Kei Hiramatsu, Ryota Yamauchi, Masafumi Shimojo, Yukiomi Tsuji, Rei Shibata, Toyoaki Murohara
No abstract text is available yet for this article.
March 21, 2024: JACC. Clinical Electrophysiology
#9
JOURNAL ARTICLE
Ahmed Shahab, Thomas L Rosamond, Amit Noheria
No abstract text is available yet for this article.
March 21, 2024: JACC. Clinical Electrophysiology
#10
JOURNAL ARTICLE
Zhaolei Jiang, Jianbing Huang, Nan Ma, Hao Liu, Sai-E Shen, Fangbao Ding, Yingman Wang, Min Tang, Ju Mei
BACKGROUND: Long-term success rates of catheter ablation (CA) for long-standing persistent atrial fibrillation (LSPAF) are less than satisfactory. Further improvement of ablation methods is crucial for enhancing the treatment of LSPAF. OBJECTIVE: This study sought to compare the outcomes of concurrent vs staged minimally invasive surgical-catheter hybrid ablation for LSPAF. METHODS: From December 2015 to December 2021, 104 matched patients (concurrent and staged, 1:1) were included in study...
March 20, 2024: JACC. Clinical Electrophysiology
#11
JOURNAL ARTICLE
Leah A John, Jeremy Bredfeldt, Zariyat Mannan, Carlos Patino, Sanjay Divakaran, Raymond Mak, William H Sauer, Paul Zei, Usha B Tedrow
No abstract text is available yet for this article.
March 16, 2024: JACC. Clinical Electrophysiology
#12
REVIEW
Francisco Lopez-Jimenez, Suraj Kapa, Paul A Friedman, Nathan K LeBrasseur, Eric Klavetter, Kathryn E Mangold, Zachi I Attia
Biological age may be a more valuable predictor of morbidity and mortality than a person's chronological age. Mathematical models have been used for decades to predict biological age, but recent developments in artificial intelligence (AI) have led to new capabilities in age estimation. Using deep learning methods to train AI models on hundreds of thousands of electrocardiograms (ECGs) to predict age results in a good, but imperfect, age prediction. The error predicting age using ECG, or the difference between AI-ECG-derived age and chronological age (delta age), may be a surrogate measurement of biological age, as the delta age relates to survival, even after adjusting for chronological age and other covariates associated with total and cardiovascular mortality...
March 14, 2024: JACC. Clinical Electrophysiology
#13
EDITORIAL
Boris Schmidt, K R Julian Chun
No abstract text is available yet for this article.
March 14, 2024: JACC. Clinical Electrophysiology
#14
JOURNAL ARTICLE
Kelly Arps, Adam S Barnett, Jonathan P Piccini, Jason I Koontz, Albert Y Sun
No abstract text is available yet for this article.
March 13, 2024: JACC. Clinical Electrophysiology
#15
EDITORIAL
Samir F Saba, Mehak Dhande
No abstract text is available yet for this article.
March 8, 2024: JACC. Clinical Electrophysiology
#16
JOURNAL ARTICLE
Osamu Inaba, Yukihiro Inamura, Takamitsu Takagi, Shin Meguro, Kentaro Nakata, Toshiki Michishita, Yuhei Isonaga, Toshikazu Kono, Shinichi Tachibana, Takashi Ikenouchi, Hiroaki Ohya, Kazuya Murata, Tomomasa Takamiya, Akira Sato, Tetsuo Sasano
BACKGROUND: Catheter ablation is the curative treatment for paroxysmal supraventricular tachycardia (SVT). However, atrial tachycardia (AT) diagnosis is often challenging, especially when SVT is terminated by pacing. OBJECTIVES: This study sought to develop a novel method for AT diagnosis. METHODS: A total of 147 SVTs including 28 ATs, 87 atrioventricular nodal re-entrant tachycardias, and 32 orthodromic reciprocating tachycardias were prospectively studied...
March 5, 2024: JACC. Clinical Electrophysiology
#17
JOURNAL ARTICLE
Mohamad Raad, Haran Yogasundaram, Justice Oranefo, Gustavo Guandalini, Timothy Markman, Matthew Hyman, Robert Schaller, Gregory Supple, Rajat Deo, Saman Nazarian, Michael Riley, David Lin, Fermin Garcia, Sanjay Dixit, Andrew E Epstein, David Callans, Francis E Marchlinski, David S Frankel
BACKGROUND: Premature ventricular complexes (PVCs) are common and associated with worse outcomes in patients with heart failure. Class 1C antiarrhythmic drugs (AADs) effectively suppress PVCs, but guidelines currently restrict their use in structural heart disease. OBJECTIVES: This study aimed to assess the safety and efficacy of class 1C AADs in patients with nonischemic cardiomyopathy (NICM) and implantable cardioverter-defibrillators (ICDs). METHODS: All patients with NICM and an ICD treated with flecainide or propafenone at the Hospital of the University of Pennsylvania between 2014 and 2022 were identified...
March 5, 2024: JACC. Clinical Electrophysiology
#18
LETTER
Christian Paludan-Müller, Niels K Stampe, Oliver B Vad, Laura Andreasen, Christian Torp-Pedersen, Lars Køber, Emil L Fosbøl, Morten S Olesen, Jesper H Svendsen
No abstract text is available yet for this article.
March 5, 2024: JACC. Clinical Electrophysiology
#19
EDITORIAL
Zachary Yoneda, Arvindh N Kanagasundram
No abstract text is available yet for this article.
March 1, 2024: JACC. Clinical Electrophysiology
#20
JOURNAL ARTICLE
Michael S Lloyd, Brett M Tomashitis, Mariana Garcia
No abstract text is available yet for this article.
February 28, 2024: JACC. Clinical Electrophysiology
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
